Case Study: RiboPro advances mRNA therapeutic research with Molecular Devices SpectraMax iD3 and iD5 readers

RiboPro measures 10–50 plates per day with Molecular Devices SpectraMax iD3

RiboPro, a biotech company specializing in mRNA therapeutics, needed a reliable instrument to determine the efficiency and toxicity of their lipid nanoparticle and mRNA formulations. Molecular Devices provided their SpectraMax iD3 Multi-Mode Microplate Reader to meet this challenge.

The solution from Molecular Devices enabled RiboPro to perform crucial luciferase, cell viability, and ELISA assays. Using the SpectraMax iD3, the company now measures between 10 and 50 plates per day, with its automatic gain settings and high throughput speeding up research and lowering service costs.

RiboPro